Carbohydrate Metabolism in Lactic Streptococci with Special Reference to Galactose

Total Page:16

File Type:pdf, Size:1020Kb

Carbohydrate Metabolism in Lactic Streptococci with Special Reference to Galactose AN ABSTRACT OF THE THESIS OF Don Royce Lee for the Doctor of Philosophy (Name) (Degree) in Microbiology presented on / 7 ; (Major) /(Dafe) Title: CARBOHYDRATE METABOLISM INLACTIC STREPTO- COCCI WITH SPECIAL REFERENCE TO GALACTOSE Redacted for Privacy Abstract approved: Dr. W. E. Sandine Phosphorylation of free galactose by lactic streptococci was mediated by an adenosine triphosphate (ATP)dependent kinase which was repressed by glucose.The phosphoenolypyruvate (PEP) phos- photransferase system (PTS) was not involved in transportof galactose, The conversion of free galactose to glucose wasalso demonstrated. A key Leloir pathway enzyme, uridinediphosphogalactose -4- epimerase, was found present with atleast 0, 66 units/mg protein in cells grown in milk or broth containing galactose orlactose.A lower level of the enzyme (0, 14units/mg protein) was found in glucose-grown cells. A modification of the standard techniquefor the assay of uridine diphosphogalactose-4-epimerase was introduced.Undialyzed crude extracts of lactic streptococcal cellscould be used for the assay but only after incorporation of 0.2 Msemicarbazide in the glycine buffer. In cell dry weight yield studies, it wasshown that glucose was the best carbohydrate for growth, andgalactose the poorest,It was, however, very difficult to show differences in growth rates of lactic streptococci using five carbohydrates.Also, in this group of organisms diauxic growth on a mixture of glucose and galactose could not be shown.Efforts were made to determine if lactic streptococci contain- ing p-D-phosphogalactoside galactohydrolase ((3 -Pgal) could utilize glucose and galactose simultaneously.Results indicated that galactose- induced cells of Streptococcus diacetilactis 18-16 could catabolize both sugars at the same time.In Streptococcus lactis 7962, however, an organism which possesses p-galactosidase (p-gal), growth curves employing both glucose and galactose revealed two distinct slopes with no lag between the time of glucose exhaustionand the time when galac- tose was utilized. In differential respirometry studies involving washed cells of S. diacetilactis 18-16, it was shown that less CO2 (< 170p,1/100 mg cell dry wt/hr. ) was evolved from galactose by glucose-induced cells, compared to that (916 p. 1 / 100 mg cell dry wt/hr.) from glucose.The inability of glucose-induced cells to catabolize galactose and lactose to the same degree as glucose was apparently due to classical catabolite repression.Lactose-induced cells evolved CO2 equally well from lactose or glucose, but the evolution of CO2 from galactose and a mixture of glucose and galactose was somewhat repressed.Galactose- induced cells required more oxygen (>1500 Ill /100 mg cell dry wt/hr.) than did glucose or lactose-induced cells (<850 [11/100 mg cell dry wt/hr.). Paper, thin layer, and column chromatographic techniques were employed in a search for galactose-6-phosphate from several wild type lactic streptococci.The compound was never detected nor was it possible to isolate it from a reaction mixture of o-nitrophenyl,3 -D, galactopyranoside-6-phosphate (ONPG-6-P) and crude cellular extracts.A search for a mutant which transported and phosphorylated lactose but was defective in cleaving the phosphorylated derivative was undertaken.Of more than 60 lactose negative mutants examined, no such mutant was found.All mutants examined lacked any detectable 3 -P -gal and also the ability to transport and phosphorylate lactose. In metabolism studies involving galactose-6-PO4, it was found that whole cells of lactic streptococci could not utilize the compound as a carbon source.Possible routes for the metabolism of this com- pound were hypothesized, and experiments were designed to test each route.The only pathway which appeared to function in its catabolism was the pentose pathway.However, it was later found that the galac- tose-6-PO4 used in these studies was contaminated with at least 0. 2 percent glucose-6-PO4 and observed activity was believeddue to the contaminant. Involvement of the PTS of transport in sugar utilization was investigated using 14C- labeled substrates andtoluene-acetone-treated cells.Substrates and phosphorylated products were separated by ion-exchange chromatography and quantitated by liquid scintillation counting.The PTS was involved in the utilization of glucose, lactose, and mannose.In controlled experiments it was determined that ATP also acted as a phosphate donor for glucose, lactose and mannose. ATP was the exclusive phosphate donor for galactose,Two transport systems appeared to act for glucose, lactose and mannose. In a survey conducted on representatives of the four major groups of streptococci, it was shownthat all lactic streptococci examined cleaved ONPG-6-P except S. lactis 7962, which cleaved 0-nitrophenyl D-galactopyranoside (ONPG).This survey also showed that all Trernbe.rs of the viridans streptococci examined possessed 6 -gal and not 13-Pgal activity. Carbohydrate Metabolism in Lactic Streptococci with Special Reference to Galactose by Don Royce Lee A THESIS submitted to Oregon State University in partial fulfillment of the requirements for the degree of Doctor of Philosophy June 1974 APPROVED: Redacted for Privacy Professor of Microbiology in charge of major Redacted for Privacy Head of Department of Microbiology Redacted for Privacy Dean of Graduate School Date thesis is presented Typed by Cheryl E. Curb for Don Royce Lee DEDICATION This thesis is dedicated to my closest friends, ACKNOWLEDGEMENTS Special gratitude is expressed to Dr. W.E. Sandine, my major professor, for his mature, Christian attitudes toward his students. Without his interest and continued help this research would never have been possible.Appreciation is also expressed to: Dr. P. R. Elliker, other staff members of the Microbiology Department, and fellow students for their knowledge and helpfulness; Members of my family for their interest and concern in my career; Faculty members of the Biology Department and Administration at East Texas State University, Commerce, Texas, for leave of absence time in which to complete this research; Tennyson and Emerson for what they left us to read and ponder; Mr. A. C. Patton for first stimulating my interest in science. Gratitude is also expressed to the Department of Microbiology, Oregon State University and the Public Health Service for assistance while completing this research.The National Science Foundation through a grant to East Texas State University partially supported the author in the beginning stages of this research. TABLE OF CONTENTS Page INTRODUCTION 1 REVIEW OF LITERATURE 6 Sugar Transport 6 The Staphylococcus aureus System 15 The Galactose Operon 19 Transport and Metabolism of Galactose 21 Galactose-6-Phosphate Metabolism 25 MATERIALS AND METHODS 29 Microorganisms 29 Chemicals 30 Media and Growth Conditions 31 Disappearance of Galactose 31 Conversion of Galactose to Glucose 32 Chromatography of Sugar Phosphates 33 Inhibition of Galactose Uptake by 6-deoxygalactose. 34 Galactose Uptake 35 Competition by Carbohydrate 35 Effect of Energy Sources 35 Effect of Metabolic Inhibitors 36 Sugar Phosphorylation Studies 36 Simultaneous Use of Glucose and Galactose by Galactose-adapted Cells of Streptococcus diacetilactis 18-16. 37 Galactose-6-Phosphate Dehydrogenase Assay 38 Galactose Oxidase Assay 39 Lactose Dehydrogenase Assay 40 Uridine Diphosphogalactose-4-Epimerase Assay 40 Inorganic Phosphate Assay 42 Assay for Galactose-l-Phosphate Uridyl Transferase 42 Differential Respirometry 43 Growth Curves 44 Mutagene sis 45 Ultraviolet Irradiation 45 Ethylmethanesulfonate (EMS) Treatment 45 Acriflavin Treatment 45 TABLE OF CONTENTS (Cont. ) Page RESULTS 47 Assay for Enzymes of Lactose Hydrolysis 47 Growth Studies 52 Differential Respirometry 65 Galactose Metabolism 75 Galactose Utilization in S. lactis C2 75 Conversion of Galactose to Glucose 76 Uridine Diphosphogalactose-4-Epimerase (UDP-gal-4-Epimerase) 80 Galactose-I-Phosphate Uridyl Transferse in Lactic Streptococci 89 Galactose Transport in S. lactis C2 89 Phosphorylation Studies 95 Metabolism of Galactose-6-Phosphate 103 DISCUSSION 105 involvement of the PTS in Carbohydrate 105 Metabolism in the Lactic Streptococci Metabolism any Transport of Free Galactose Growth Studies and Differential Respirometry Metabolism of Galactose-6-Phosphate SUMMARY 122 BIBLIOGRAPHY 124 LIST OF TABLES Table Page 1 Specific activity of p-galactosidase (p-gal) and 3, D- phosphogalactoside galactohydrolase (p-P-gal) in various streptococci. 49 2 Characteristics of selected streptococci as determined using the API system for characterizing the lactic acid bacteria. 51 3 Cell dry weight yields of S. lactis G2 grown in five different carbohydrates. 55 4 The specific activity of CO2 evolved by galactose adapted cells of S. diacetilactis 18-16 over a 30 minute period at 30 C in different carbohydrates. 64 5 C O7 evolved and 02 absorbed by cells of S. diacetilactls 13-16 when induced in galactose and returned to four different substrates. 74 Galactose oxidase activity of S. diacetilactis 18-16 in various carbohydrates. 75 7 The influence of PEP, ATP and KF on the utilization of galactose by resting, toluene-acetone-treated, galactose-grown cells of S. lactis C2. 76 8 Compounds formed from galactose by toluene- acetone-treated, resting cells of S. lactis G2 grown (six hour) on galactose. 77 9 Activity of UDP- galactose -4- epimerase in S. lactis C2 when grown in different carbohydrates to late log phase. 86 10 Activity of UDP-galactose-4-epimerase from various lactic streptococci grown to late log phase in galactose broth. 88 LIST OF TABLES (Cont. ) Table Page 11 Galactose transport in S. lactis C2 and the effect of competing carbohydrates. 90 12 Galactose transport in S. lactis C2 and the effect of metabolic inhibitors. 92 13 Galactose transport in S. lactis C2 and the effect of energy sources, 93 14 Role of ATP and PEP in phosphorylation of various sugars by S. lactis C2 induced on five different carbon sources. 96 15 Phosphorylation of four growth substrates by S cremoris Hp and a S. cremoris Hp Lac- mutant. 99 16 Percent phosphorylation of various carbohydrates by S. lactis C2 mutants. 100 17 Characteristics of some selected lac- mutants of S.
Recommended publications
  • Itraq-Based Quantitative Proteomics Analysis Reveals the Mechanism Underlying the Weakening of Carbon Metabolism in Chlorotic Tea Leaves
    Article iTRAQ-Based Quantitative Proteomics Analysis Reveals the Mechanism Underlying the Weakening of Carbon Metabolism in Chlorotic Tea Leaves Fang Dong 1,2, Yuanzhi Shi 1,2, Meiya Liu 1,2, Kai Fan 1,2, Qunfeng Zhang 1,2,* and Jianyun Ruan 1,2 1 Tea Research Institute, Chinese Academy of Agricultural Sciences, Hangzhou 310008, China; [email protected] (F.D.); [email protected] (Y.S.); [email protected] (M.L.); [email protected] (K.F.); [email protected] (J.R.) 2 Key Laboratory for Plant Biology and Resource Application of Tea, the Ministry of Agriculture, Hangzhou 310008, China * Correspondence: [email protected]; Tel.: +86-571-8527-0665 Received: 7 November 2018; Accepted: 5 December 2018; Published: 7 December 2018 Abstract: To uncover mechanism of highly weakened carbon metabolism in chlorotic tea (Camellia sinensis) plants, iTRAQ (isobaric tags for relative and absolute quantification)-based proteomic analyses were employed to study the differences in protein expression profiles in chlorophyll-deficient and normal green leaves in the tea plant cultivar “Huangjinya”. A total of 2110 proteins were identified in “Huangjinya”, and 173 proteins showed differential accumulations between the chlorotic and normal green leaves. Of these, 19 proteins were correlated with RNA expression levels, based on integrated analyses of the transcriptome and proteome. Moreover, the results of our analysis of differentially expressed proteins suggested that primary carbon metabolism (i.e., carbohydrate synthesis and transport) was inhibited in chlorotic tea leaves. The differentially expressed genes and proteins combined with photosynthetic phenotypic data indicated that 4-coumarate-CoA ligase (4CL) showed a major effect on repressing flavonoid metabolism, and abnormal developmental chloroplast inhibited the accumulation of chlorophyll and flavonoids because few carbon skeletons were provided as a result of a weakened primary carbon metabolism.
    [Show full text]
  • Engineering the Substrate Specificity of Galactose Oxidase
    Engineering the Substrate Specificity of Galactose Oxidase Lucy Ann Chappell BSc. (Hons) Submitted in accordance with the requirements for the degree of Doctor of Philosophy The University of Leeds School of Molecular and Cellular Biology September 2013 The candidate confirms that the work submitted is her own and that appropriate credit has been given where reference has been made to the work of others. This copy has been supplied on the understanding that it is copyright material and that no quotation from the thesis may be published without proper acknowledgement © 2013 The University of Leeds and Lucy Ann Chappell The right of Lucy Ann Chappell to be identified as Author of this work has been asserted by her in accordance with the Copyright, Designs and Patents Act 1988. ii Acknowledgements My greatest thanks go to Prof. Michael McPherson for the support, patience, expertise and time he has given me throughout my PhD. Many thanks to Dr Bruce Turnbull for always finding time to help me with the Chemistry side of the project, particularly the NMR work. Also thanks to Dr Arwen Pearson for her support, especially reading and correcting my final thesis. Completion of the laboratory work would not have been possible without the help of numerous lab members and friends who have taught me so much, helped develop my scientific skills and provided much needed emotional support – thank you for your patience and friendship: Dr Thembi Gaule, Dr Sarah Deacon, Dr Christian Tiede, Dr Saskia Bakker, Ms Briony Yorke and Mrs Janice Robottom. Thank you to three students I supervised during my PhD for their friendship and contributions to the project: Mr Ciaran Doherty, Ms Lito Paraskevopoulou and Ms Upasana Mandal.
    [Show full text]
  • Generated by SRI International Pathway Tools Version 25.0, Authors S
    Authors: Pallavi Subhraveti Ron Caspi Quang Ong Peter D Karp An online version of this diagram is available at BioCyc.org. Biosynthetic pathways are positioned in the left of the cytoplasm, degradative pathways on the right, and reactions not assigned to any pathway are in the far right of the cytoplasm. Transporters and membrane proteins are shown on the membrane. Ingrid Keseler Periplasmic (where appropriate) and extracellular reactions and proteins may also be shown. Pathways are colored according to their cellular function. Gcf_000725805Cyc: Streptomyces xanthophaeus Cellular Overview Connections between pathways are omitted for legibility.
    [Show full text]
  • ( 12 ) United States Patent
    US010195209B2 (12 ) United States Patent ( 10 ) Patent No. : US 10 , 195 ,209 B2 Gish et al. (45 ) Date of Patent: * Feb . 5 , 2019 (54 ) ANTI- HULRRC15 ANTIBODY DRUG 4 ,634 ,665 A 1 / 1987 Axel 4 ,716 , 111 A 12 / 1987 Osband CONJUGATES AND METHODS FOR THEIR 4 ,737 , 456 A 4 / 1988 Weng USE 4 , 816 ,397 A 3 / 1989 Boss 4 , 816 ,457 A 3 / 1989 Baldwin (71 ) Applicants :AbbVie Inc. , North Chicago , IL (US ) ; 4 , 968 ,615 A 11 / 1990 Koszinowski AbbVie Biotherapeutics Inc. , 5 , 168 , 062 A 12 / 1992 Stinski 5 , 179 ,017 A 1 / 1993 Axel Redwood City , CA (US ) 5 , 225 , 539 A 7 / 1993 Winter 5 , 413 , 923 A 5 / 1995 Kucherlapati ( 72 ) Inventors : Kurt C . Gish , Piedmont, CA (US ) ; 5 ,530 , 101 A 6 /1996 Queen Jonathan A . Hickson , Lake Villa , IL 5 , 545 , 806 A 8 / 1996 Lonberg (US ) ; Susan Elizabeth Morgan - Lappe , 5 , 565 ,332 A 10 / 1996 Hoogenboom Riverwoods, IL (US ) ; James W . 5 , 569 , 825 A 10 / 1996 Lonberg 5 ,585 ,089 A 12 / 1996 Queen Purcell, San Francisco , CA (US ) 5 ,625 , 126 A 4 / 1997 Lonberg 5 ,633 , 425 A 5 / 1997 Lonberg ( 73 ) Assignees: AbbVie Inc. , North Chicago , IL (US ) ; 5 ,658 , 570 A 8 / 1997 Newman AbbVie Biotherapeutics Inc . , 5 ,661 ,016 A 8 / 1997 Lonberg Redwood City , CA (US ) 5 ,681 , 722 A 10 / 1997 Newman 5 ,693 , 761 A 12 / 1997 Queen 5 ,693 , 762 A 12 / 1997 Queen ( * ) Notice : Subject to any disclaimer, the term of this 5 ,693 , 780 A 12 / 1997 Newman patent is extended or adjusted under 35 5 , 807 ,715 A 9 / 1998 Morrison U .
    [Show full text]
  • WO 2012/170711 Al 13 December 2012 (13.12.2012) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2012/170711 Al 13 December 2012 (13.12.2012) P O P C T (51) International Patent Classification: (72) Inventors; and G01N33/5 74 (2006.01) (75) Inventors/Applicants (for US only): PAWLOWSKI, Traci [US/US]; 2014 N Milkweed Loop, Phoenix, AZ (21) International Application Number: 85037 (US). YEATTS, Kimberly [US/US]; 109 E. Pierce PCT/US2012/041387 Street, Tempe, AZ 85281 (US). AKHAVAN, Ray (22) International Filing Date: [US/US]; 5804 Malvern Hill Ct, Haymarket, VA 201 69 7 June 2012 (07.06.2012) (US). (25) Filing Language: English (74) Agent: AKHAVAN, Ramin; Caris Science, Inc., 6655 N. MacArthur Blvd., Irving, TX 75039 (US). (26) Publication Language: English (81) Designated States (unless otherwise indicated, for every (30) Priority Data: kind of national protection available): AE, AG, AL, AM, 61/494,196 7 June 201 1 (07.06.201 1) AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, 61/494,355 7 June 201 1 (07.06.201 1) CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, 61/507,989 14 July 201 1 (14.07.201 1) DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, (71) Applicant (for all designated States except US): CARIS HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, LIFE SCIENCES LUXEMBOURG HOLDINGS, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, S.A.R.L [LU/LU]; Rue De Maraichers, L2124 Luxem MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, bourg, Grand-Duche De Luxembourg (LU).
    [Show full text]
  • WO 2012/174282 A2 20 December 2012 (20.12.2012) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2012/174282 A2 20 December 2012 (20.12.2012) P O P C T (51) International Patent Classification: David [US/US]; 13539 N . 95th Way, Scottsdale, AZ C12Q 1/68 (2006.01) 85260 (US). (21) International Application Number: (74) Agent: AKHAVAN, Ramin; Caris Science, Inc., 6655 N . PCT/US20 12/0425 19 Macarthur Blvd., Irving, TX 75039 (US). (22) International Filing Date: (81) Designated States (unless otherwise indicated, for every 14 June 2012 (14.06.2012) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, English (25) Filing Language: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, Publication Language: English DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, (30) Priority Data: KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, 61/497,895 16 June 201 1 (16.06.201 1) US MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, 61/499,138 20 June 201 1 (20.06.201 1) US OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, 61/501,680 27 June 201 1 (27.06.201 1) u s SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, 61/506,019 8 July 201 1(08.07.201 1) u s TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
    [Show full text]
  • ENZYME BASED METHODS for LACTATE DETERMINATION Andriana Surleva1, Anna Marinova1, Vladislava Ivanova2, Robert Gradinaru3, Stela Georgieva1
    Andriana Surleva,Journal Annaof Chemical Marinova, Technology Vladislava and Ivanova, Metallurgy, Robert 52, Gradinaru,3, 2017, 513-525 Stela Georgieva ENZYME BASED METHODS FOR LACTATE DETERMINATION Andriana Surleva1, Anna Marinova1, Vladislava Ivanova2, Robert Gradinaru3, Stela Georgieva1 1 Analytical Chemistry Department Received 07 November 2016 University of Chemical Technology and Metallurgy Accepted 22 January 2017 8 Kl. Ohridski, 1756 Sofia, Bulgaria E-mail: [email protected] 2Physics Department University of Chemical Technology and Metallurgy 8 Kl. Ohridski, 1756 Sofia, Bulgaria 3 Biochemistry group, Faculty of Chemistry “Alexandru Ioan Cuza” University of Iasi Iasi, Romania ABSTRACT Development of biosensors for lactate determination has gained an increased research interest because of their wide application in clinical analysis and control of fermentation processes in food industry. Lactate biosensors with enzyme modified modules are a perspective alternative to the conventional methods in clinical analysis for their fast response, applicability to continuous mode of analysis, low cost and easy automation. Food and beverage indus- try can also benefit of the advantages of lactate biosensors for monitoring of fermentation processes or control of foods labeled as “low lactate content”. The quantification of low lactate levels demands for sensitive and reliable analytical methods for lactate quantification in complex matrices. This review discusses the enzymatic methods for lactate determination. Recent advances in lactate biosensors
    [Show full text]
  • Regulated T Cell Pre-Mrna Splicing As Genetic Marker of T Cell Suppression
    Regulated T cell pre-mRNA splicing as genetic marker of T cell suppression by Boitumelo Mofolo Thesis presented for the degree of Master of Science (Bioinformatics) Institute of Infectious Disease and Molecular Medicine University of Cape Town (UCT) Supervisor: Assoc. Prof. Nicola Mulder August 2012 University of Cape Town The copyright of this thesis vests in the author. No quotation from it or information derived from it is to be published without full acknowledgementTown of the source. The thesis is to be used for private study or non- commercial research purposes only. Cape Published by the University ofof Cape Town (UCT) in terms of the non-exclusive license granted to UCT by the author. University Declaration I, Boitumelo Mofolo, declare that all the work in this thesis, excluding that has been cited and referenced, is my own. Signature Signature Removed Boitumelo Mofolo University of Cape Town Copyright©2012 University of Cape Town All rights reserved 1 ABSTRACT T CELL NORMAL T CELL SUPPRESSION p110 p110 MV p85 PI3K AKT p85 PI3K PHOSPHORYLATION NO PHOSHORYLATION HIV cytoplasm HCMV LCK-011 PRMT5-006 SHIP145 SIP110 RV LCK-010 VCL-204 ATM-016 PRMT5-018 ATM-002 CALD1-008 LCK-006 MXI1-001 VCL-202 NRP1-201 MXI1-007 CALD1-004 nucleus Background: Measles is a highly contagious disease that mainly affects children and according to the World Health Organisation (WHO), was responsible for over 164000 deaths in 2008, despite the availability of a safe and cost-effective vaccine [56]. The Measles virus (MV) inactivates T- cells, rendering them dysfunctional, and results in virally induced immunosuppression which shares certain features with thatUniversity induced by HIV.
    [Show full text]
  • Development Perspective of Bioelectrocatalysis-Based Biosensors
    sensors Review Development Perspective of Bioelectrocatalysis-Based Biosensors , Taiki Adachi, Yuki Kitazumi, Osamu Shirai and Kenji Kano * y Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Sakyo, Kyoto 606-8502, Japan; [email protected] (T.A.); [email protected] (Y.K.); [email protected] (O.S.) * Correspondence: [email protected] Present address: Center for Advanced Science and Innovation, Kyoto University, Gokasho, Uji, y Kyoto 611-0011, Japan. Received: 19 July 2020; Accepted: 25 August 2020; Published: 26 August 2020 Abstract: Bioelectrocatalysis provides the intrinsic catalytic functions of redox enzymes to nonspecific electrode reactions and is the most important and basic concept for electrochemical biosensors. This review starts by describing fundamental characteristics of bioelectrocatalytic reactions in mediated and direct electron transfer types from a theoretical viewpoint and summarizes amperometric biosensors based on multi-enzymatic cascades and for multianalyte detection. The review also introduces prospective aspects of two new concepts of biosensors: mass-transfer-controlled (pseudo)steady-state amperometry at microelectrodes with enhanced enzymatic activity without calibration curves and potentiometric coulometry at enzyme/mediator-immobilized biosensors for absolute determination. Keywords: current–potential curve; multi-enzymatic cascades; multianalyte detection; mass-transfer-controlled amperometric response; potentiometric coulometry 1. Introduction Electron transfer reactions such as photosynthesis, respiration and metabolisms play an important role in all living things. A huge variety of redox enzymes catalyze the oxidation and reduction of couples of two inherent substrates. Usually, the electrons are transferred between the two substrates through a cofactor(s) that is covalently or non-covalently bound to the redox enzymes.
    [Show full text]
  • Enzyme-Based Amperometric Galactose Biosensors: a Review
    Microchim Acta DOI 10.1007/s00604-017-2465-z REVIEW ARTICLE Enzyme-based amperometric galactose biosensors: a review Prosper Kanyong1,2 & Francis D. Krampa1,3 & Yaw Aniweh 1 & Gordon A. Awandare 1,3 Received: 26 May 2017 /Accepted: 14 August 2017 # The Author(s) 2017. This article is an open access publication Abstract This review (with 35 references) summarizes the Introduction various strategies used in biosensors for galactose, and their analytical performance. A brief comparison of the enzyme The quantitative determination of galactose is of great impor- immobilization methods employed and the analytical perfor- tance in clinical chemistry, food and fermentation industries. mance characteristics of a range of galactose biosensors are There are two general analytical methods for the analysis of first summarized in tabular form and then described in detail. galactose in real samples, namely, separation by liquid or gas Selected examples have been included to demonstrate the var- chromatography, and enzyme-based methods using galactose ious applications of these biosensors to real samples. oxidase (GalOx) or galactose dehydrogenase (GADH) in con- Following an introduction into the field that covers the signif- junction with spectrophotometric, polarimetric, and fluo- icance of sensing galactose in various fields, the review covers rometric detection of enzymatic products [1, 2]. Several com- biosensors based on the use of galactose oxidase, with a dis- mercial assay kits based on GADH have been developed. cussion of methods for their immobilization (via cross- However, these methods are usually cumbersome and expen- linking, adsorption, covalent bonding and entrapment). This sive, time-consuming and often require skilled personnel to is followed by a short section on biosensors based on the use operate them [1–3].
    [Show full text]
  • Glucose Oxidase (G2133)
    Glucose Oxidase, Type VII from Aspergillus niger Catalog Number G2133 Storage Temperature –20 C CAS RN 9001-37-0 Substrates: Glucose oxidase is relatively specific for 7,8 EC 1.1.3.4 -D-glucose (KM of 33–110 mM) It also oxidizes Synonyms: Gox; -D-Glucose:oxygen D-aldohexoses, monodeoxy-D-glucoses, and methyl- 1-oxidoreductase D-glucoses at varying rates. The following substrates are listed in decreasing order of oxidation rate: Product Description D-glucose, 2-deoxy-D-glucose, 4-O-methyl-D-glucose, Glucose oxidase catalyzes the oxidation of -D-glucose 6-deoxy-D-glucose, 4-deoxy-D-glucose, 3-deoxy- to form D-glucono-1,5-lactone and hydrogen peroxide. D-glucose, 3-O-methyl-D-glucose -D-glucose + O2 → D-glucono-1,5-lactone + H2O2 One publication has examined kinetics data and structural data to postulate on the chemical mechanism 9 Glucose oxidase can be utilized for the enzymatic of action of glucose oxidase from A. niger. The role of determination of D-glucose in solution. As glucose FAD in the oxidation of glucose, as catalyzed by glucose oxidase from A. niger, has been investigated oxidase oxidizes -D-glucose to D-gluconolactate and 10 hydrogen peroxide, horseradish peroxidase is often using electrospray ionization mass spectrometry. The crystal structure of a partially deglycosylated form of used as the coupling enzyme in glucose 11 determinations. Although glucose oxidase is specific glucose oxidase from A. niger has been reported. for -D-glucose, solutions of D-glucose can be quantified, as -D-glucose will mutorotate to This product is supplied as a lyophilized powder containing phosphate buffer salts and sodium chloride.
    [Show full text]
  • All Enzymes in BRENDA™ the Comprehensive Enzyme Information System
    All enzymes in BRENDA™ The Comprehensive Enzyme Information System http://www.brenda-enzymes.org/index.php4?page=information/all_enzymes.php4 1.1.1.1 alcohol dehydrogenase 1.1.1.B1 D-arabitol-phosphate dehydrogenase 1.1.1.2 alcohol dehydrogenase (NADP+) 1.1.1.B3 (S)-specific secondary alcohol dehydrogenase 1.1.1.3 homoserine dehydrogenase 1.1.1.B4 (R)-specific secondary alcohol dehydrogenase 1.1.1.4 (R,R)-butanediol dehydrogenase 1.1.1.5 acetoin dehydrogenase 1.1.1.B5 NADP-retinol dehydrogenase 1.1.1.6 glycerol dehydrogenase 1.1.1.7 propanediol-phosphate dehydrogenase 1.1.1.8 glycerol-3-phosphate dehydrogenase (NAD+) 1.1.1.9 D-xylulose reductase 1.1.1.10 L-xylulose reductase 1.1.1.11 D-arabinitol 4-dehydrogenase 1.1.1.12 L-arabinitol 4-dehydrogenase 1.1.1.13 L-arabinitol 2-dehydrogenase 1.1.1.14 L-iditol 2-dehydrogenase 1.1.1.15 D-iditol 2-dehydrogenase 1.1.1.16 galactitol 2-dehydrogenase 1.1.1.17 mannitol-1-phosphate 5-dehydrogenase 1.1.1.18 inositol 2-dehydrogenase 1.1.1.19 glucuronate reductase 1.1.1.20 glucuronolactone reductase 1.1.1.21 aldehyde reductase 1.1.1.22 UDP-glucose 6-dehydrogenase 1.1.1.23 histidinol dehydrogenase 1.1.1.24 quinate dehydrogenase 1.1.1.25 shikimate dehydrogenase 1.1.1.26 glyoxylate reductase 1.1.1.27 L-lactate dehydrogenase 1.1.1.28 D-lactate dehydrogenase 1.1.1.29 glycerate dehydrogenase 1.1.1.30 3-hydroxybutyrate dehydrogenase 1.1.1.31 3-hydroxyisobutyrate dehydrogenase 1.1.1.32 mevaldate reductase 1.1.1.33 mevaldate reductase (NADPH) 1.1.1.34 hydroxymethylglutaryl-CoA reductase (NADPH) 1.1.1.35 3-hydroxyacyl-CoA
    [Show full text]